RxDoctor Payments Data

Christopher Melani

Internal Medicine · Baltimore, MDNPI 1922307230

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, AstraZeneca. That places this record below the midpoint for internal medicine clinicians in MD, where the typical reported total is $161.

$135in general payments, 2019–2025

Across 1 payment — averaging $135.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$135
$996,448in research payments, 2019–2025

Across 9 payments — averaging $110,716 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$668K
  • Adaptive Biotechnologies Corporation$325K
  • Bristol Myers Squibb$4K

What the payments were for

  • Food & beverage$135100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$135

How this compares

$135 in reported general payments places this provider in the 45th percentile of 2,979 internal medicine providers in Maryland.

See all internal medicine providers in Maryland →

Other internal medicine in Baltimore

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →